DELMAR PHARMACEUTICALS INC's ticker is DMPI and the CUSIP is 247078207. A total of 10 filers reported holding DELMAR PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $48,000 | +182.4% | 98,554 | +99.7% | 0.00% | +200.0% |
| Q4 2018 | $17,000 | -15.0% | 49,354 | +78.9% | 0.00% | 0.0% |
| Q3 2018 | $20,000 | -47.4% | 27,582 | -49.3% | 0.00% | -50.0% |
| Q2 2018 | $38,000 | +8.6% | 54,411 | +44.4% | 0.00% | 0.0% |
| Q1 2018 | $35,000 | +118.8% | 37,685 | +103.0% | 0.00% | +100.0% |
| Q3 2017 | $16,000 | – | 18,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 54,411 | $38,000 | 0.00% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 5,000 | $3,000 | 0.00% |
| FRANKLIN RESOURCES INC | 804,000 | $551,000 | 0.00% |
| CREDIT SUISSE AG/ | 13,000 | $9,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 4,262 | $3,000 | 0.00% |
| Citadel Advisors | 22,260 | $15,000 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 12,500 | $9,000 | 0.00% |
| ROYAL BANK OF CANADA | 500 | $0 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 42,375 | $40,000 | 0.00% |
| UBS Group AG | 9,646 | $7,000 | 0.00% |